Shares of Synopsys, Inc. (NASDAQ:SNPS) have been given a consensus rating of “Buy” by the nine analysts that are currently covering the firm. Two research analysts have rated the stock with a hold rating and seven have …
Target Corporation
Synopsys, Inc. (NASDAQ:SNPS) is expected to get fairly healthy orders for its software despite an uncertain …
Economic Outlook
Synopsys, Inc. (NASDAQ:SNPS) has earned a consensus rating of "Buy" from the nine research firms that are now covering the company. They …
Analyst
Synopsys Inc. (SNPS) traded on unusually high volume on Feb. 21, as the stock gained 0.67% to close at $70.98. On the day, Synopsys Inc. saw 1.29 million shares trade hands on 13,736 trades. Considering that …
Synopsys
With its market value over its outstanding shares, China Petroleum & Chemical Corporation (NYSE:SNP) Major Integrated Oil & Gas has a market capitalization valued at Major Integrated Oil & Gas. As the outstanding …
Sinopec
In Q1, we returned $100 million to shareholders through our stock buyback program. In 2017, we intend to slightly reduce share count, and we have $335 million remaining on our current authorization. Now to the quarter and …
Synopsys
Meanwhile, the Bucharest Stock Exchange is still far from the historical …
Bucharest Stock Exchange
Stock market analysts watching WAVE Life Sciences Ltd. (WVE ... In Huntington’s disease, it has programs that target HTT SNP-1 and HTT SNP-2; in DMD, it targets Exon 51, and in IBD, it targets SMAD7. It has selected …
Binary code converter Second, dissection of multivariate association signals is achieved through model …
Software